This is a demo store. No orders will be fulfilled.

Rosuvastatin Calcium - ≥99%, high purity , HMG-CoA reductase inhibitor, CAS No.147098-20-2, HMG-CoA reductase inhibitor

In stock
Item Number
R129220
Grouped product items
SKU Size
Availability
Price Qty
R129220-25mg
25mg
5
$9.90
R129220-100mg
100mg
3
$19.90
R129220-200mg
200mg
3
$29.90
R129220-1g
1g
1
$49.90
R129220-5g
5g
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$99.90
R129220-25g
25g
2
$319.90

Potent HMG-CoA reductase inhibitor

Basic Description

Synonyms Shufutan | Suvikan | Provisacor | ROSUVASTATIN CALCIUM (USP-RS) | ROSUVASTATIN CALCIUM [EP MONOGRAPH] | R0180 | EZALLOR | Rosuvastatin calcium | Rosuvastatin calcium- Bio-X | ZD 4522 Calcium
Specifications & Purity Moligand™, ≥99%
Biochemical and Physiological Mechanisms Potent HMG-CoA reductase inhibitor (IC50= 5.4 nM). Inhibits cholesterol synthesis in rat hepatocytesin vitroandin vivo. Reduces plasma LDL cholesterol levels. Enhances lentiviral transduction of natural killer cells. Orally bioavailable.
Storage Temp Store at -20°C
Shipped In
Ice chest + Ice pads
This product requires cold chain shipping. Ground and other economy services are not available.
Grade Moligand™
Action Type INHIBITOR
Mechanism of action HMG-CoA reductase inhibitor
Product Description

Rosuvastatin Calcium is a competitive inhibitor of HMG-CoA reductase with IC50 of 11 nM.
A selective and competitive inhibitor of HMG-CoA reductase.

Taxonomic Classification

Taxonomy Tree

Kingdom Organic compounds
Superclass Organoheterocyclic compounds
Class Diazines
Subclass Pyrimidines and pyrimidine derivatives
Intermediate Tree Nodes Not available
Direct Parent Phenylpyrimidines
Alternative Parents Medium-chain hydroxy acids and derivatives  Medium-chain fatty acids  Beta hydroxy acids and derivatives  Fluorobenzenes  Halogenated fatty acids  Heterocyclic fatty acids  Hydroxy fatty acids  Aryl fluorides  Unsaturated fatty acids  Organosulfonamides  Organic sulfonamides  Heteroaromatic compounds  Aminosulfonyl compounds  Secondary alcohols  Carboxylic acid salts  Monocarboxylic acids and derivatives  Azacyclic compounds  Carboxylic acids  Organic calcium salts  Organic metal halides  Organic zwitterions  Organofluorides  Organonitrogen compounds  Hydrocarbon derivatives  Organopnictogen compounds  Carbonyl compounds  Organic oxides  
Molecular Framework Not available
Substituents 4-phenylpyrimidine - 5-phenylpyrimidine - Medium-chain hydroxy acid - Medium-chain fatty acid - Beta-hydroxy acid - Fluorobenzene - Halobenzene - Halogenated fatty acid - Heterocyclic fatty acid - Hydroxy fatty acid - Fatty acid - Hydroxy acid - Benzenoid - Fatty acyl - Monocyclic benzene moiety - Aryl halide - Unsaturated fatty acid - Aryl fluoride - Organosulfonic acid amide - Organic sulfonic acid amide - Heteroaromatic compound - Aminosulfonyl compound - Organosulfonic acid or derivatives - Organic sulfonic acid or derivatives - Sulfonyl - Carboxylic acid salt - Secondary alcohol - Organic metal halide - Azacycle - Carboxylic acid derivative - Organic calcium salt - Carboxylic acid - Monocarboxylic acid or derivatives - Organooxygen compound - Organosulfur compound - Organic oxygen compound - Organopnictogen compound - Organic oxide - Organic salt - Hydrocarbon derivative - Carbonyl group - Alcohol - Organic nitrogen compound - Organic zwitterion - Organohalogen compound - Organofluoride - Organonitrogen compound - Aromatic heteromonocyclic compound
Description This compound belongs to the class of organic compounds known as phenylpyrimidines. These are polycyclic aromatic compounds containing a benzene ring linked to a pyrimidine ring through a CC or CN bond. Pyrimidine is a 6-membered ring consisting of four carbon atoms and two nitrogen centers at the 1- and 3- ring positions.
External Descriptors organic calcium salt - N-acyl-15-methylhexadecasphinganine-1-phosphoethanolamine

Associated Targets(Human)

HMGCR Tclin HMG-CoA reductase (2475 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
RXRA Tclin Retinoid X receptor alpha (3637 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Homo sapiens (32628 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
ABCC2 Tchem Canalicular multispecific organic anion transporter 1 (1191 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
ABCB11 Tchem Bile salt export pump (2311 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
ABCC3 Tbio Canalicular multispecific organic anion transporter 2 (718 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
ABCC4 Tchem Multidrug resistance-associated protein 4 (785 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID

Associated Targets(non-human)

MDCK (10148 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
rep Replicase polyprotein 1ab (378 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID

Mechanisms of Action

Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References

Names and Identifiers

Pubchem Sid 504763431
Pubchem Sid Url https://pubchem.ncbi.nlm.nih.gov/substance/504763431
IUPAC Name calcium;(E,3R,5S)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoate
INCHI InChI=1S/2C22H28FN3O6S.Ca/c2*1-13(2)20-18(10-9-16(27)11-17(28)12-19(29)30)21(14-5-7-15(23)8-6-14)25-22(24-20)26(3)33(4,31)32;/h2*5-10,13,16-17,27-28H,11-12H2,1-4H3,(H,29,30);/q;;+2/p-2/b2*10-9+;/t2*16-,17-;/m11./s1
InChIKey LALFOYNTGMUKGG-BGRFNVSISA-L
Smiles CC(C)C1=NC(=NC(=C1C=CC(CC(CC(=O)[O-])O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C.CC(C)C1=NC(=NC(=C1C=CC(CC(CC(=O)[O-])O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C.[Ca+2]
Isomeric SMILES CC(C1=NC(=NC(=C1/C=C/[C@@H](O)C[C@@H](O)CC(=O)[O-])C2=CC=C(C=C2)F)N(S(=O)(=O)C)C)C.CC(C1=NC(=NC(=C1/C=C/[C@@H](O)C[C@@H](O)CC(=O)[O-])C2=CC=C(C=C2)F)N(S(=O)(=O)C)C)C.[Ca+2]
PubChem CID 5282455
Molecular Weight 500.57

Certificates(CoA,COO,BSE/TSE and Analysis Chart)

C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

14 results found

Lot Number Certificate Type Date Item
C2521627 Certificate of Analysis Feb 11, 2025 R129220
C2521628 Certificate of Analysis Feb 11, 2025 R129220
G2510091 Certificate of Analysis Feb 11, 2025 R129220
A2507184 Certificate of Analysis Jan 10, 2025 R129220
A2513115 Certificate of Analysis Jan 10, 2025 R129220
B1911194 Certificate of Analysis Jul 10, 2024 R129220
F2129357 Certificate of Analysis Apr 14, 2023 R129220
F1502097 Certificate of Analysis Jan 25, 2023 R129220
B1911193 Certificate of Analysis Oct 17, 2022 R129220
K2310017 Certificate of Analysis Jul 27, 2022 R129220
J2210694 Certificate of Analysis Jul 27, 2022 R129220
J2210115 Certificate of Analysis Jul 27, 2022 R129220
J2211168 Certificate of Analysis Jul 27, 2022 R129220
J2210695 Certificate of Analysis Jul 27, 2022 R129220

Show more⌵

Chemical and Physical Properties

Solubility Solvent:DMSO, Max Conc. mg/mL: 50.06, Max Conc. mM: 100
Sensitivity heat sensitive
Specific Rotation[α] -8° (C=1,CHCl3)
Melt Point(°C) 160 °C
Molecular Weight 1001.100 g/mol
XLogP3
Hydrogen Bond Donor Count 4
Hydrogen Bond Acceptor Count 20
Rotatable Bond Count 18
Exact Mass 1000.28 Da
Monoisotopic Mass 1000.28 Da
Topological Polar Surface Area 304.000 Ų
Heavy Atom Count 67
Formal Charge 0
Complexity 761.000
Isotope Atom Count 0
Defined Atom Stereocenter Count 4
Undefined Atom Stereocenter Count 0
Defined Bond Stereocenter Count 2
Undefined Bond Stereocenter Count 0
The total count of all stereochemical bonds 2
Covalently-Bonded Unit Count 3

Citations of This Product

1. Jie Yang, Xiuhua Pan, Jun Zhang, Siyu Ma, Jianeng Zhou, Zengguang Jia, Yawen Wei, Zengyi Liu, Ning Yang, Qi Shen.  (2022)  Reprogramming dysfunctional dendritic cells by a versatile metabolism nano-intervenor for enhancing cancer combinatorial immunotherapy.  Nano Today,  46  (101618). 
2. Jie Yang, Zengguang Jia, Jun Zhang, Xiuhua Pan, Yawen Wei, Siyu Ma, Ning Yang, Zengyi Liu, Qi Shen.  (2022)  Metabolic Intervention Nanoparticles for Triple-Negative Breast Cancer Therapy via Overcoming FSP1-Mediated Ferroptosis Resistance.  Advanced Healthcare Materials,  11  (13): (2102799). 
3. Xie Qiu-shi, Zhang Jia-xin, Liu Ming, Liu Pei-hua, Wang Zhong-jian, Zhu Liang, Jiang Ling, Jin Meng-meng, Liu Xiao-nan, Liu Li, Liu Xiao-dong.  (2020)  Short-chain fatty acids exert opposite effects on the expression and function of p-glycoprotein and breast cancer resistance protein in rat intestine.  ACTA PHARMACOLOGICA SINICA,  42  (3): (470-481). 
4. Kyeong-Ju Lee, Yoon-Mi Lee, Seong-Bin Yang, Jun-Hyuck Lee, Ha Rin Kim, Ji-Hong Lim, Jooho Park.  (2024)  A novel chemically engineered multifunctional statin conjugate as self-assembled nanoparticles inhibiting bile acid transporters.  JOURNAL OF CONTROLLED RELEASE,  372  (885). 

Solution Calculators

Reviews

Customer Reviews

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.